Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) supports teams developing adaptive drug and biologic trials to evaluate treatments faster, at lower cost, and with fewer participants.
SPECTRA: Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency supports research teams developing autism assessments, AI models, and tailored care to improve independence and quality of life.
Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.
ACCESS Award supports clinical research teams testing low-cost, scalable cancer interventions to improve treatment and expand equitable access worldwide, particularly in low- and middle-income countries.
Small Business Award Opportunities support small businesses developing transformative health technologies, funding research and development to advance high-impact innovations toward commercialization.
Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing repurposed therapies to address unsolved diseases in underserved and priority patient groups.